AMB 011
Alternative Names: AMB-011Latest Information Update: 25 Aug 2023
At a glance
- Originator AIMEDBIO
- Class Bispecific antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research CNS disorders
Most Recent Events
- 12 Jul 2023 Early research in CNS disorders in South Korea (Parenteral) (AIMEDBIO pipeline, July 2023)